Iress Limited

This report is an updated version of the report published on the 25^th November 2022 at 3:55PM (GMT+11). 

Section 1: Company Overview and Fundamentals

1.1 Company Overview:

Iress Limited (ASX: IRE) offers information, trading, compliance, portfolio management, order management, wealth management, and related tools. The company has its business operations across Asia-Pacific, Australia, North America, Africa, and the UK & Europe. The company was listed on ASX in 2000, and its software is utilised by more than 500,000 users worldwide.  

1.2 The Key Positives, Negatives, Investment Highlights, and Risks

1.3 Top 10 Shareholders: The top 10 shareholders together form ~49.92% of the total shareholding. Challenger Managed Investments Ltd. and Greencape Capital Pty. Ltd. hold a maximum stake in the company at ~7.22% and ~7.10%, respectively.

1.4 Key Metrics: During 1HFY22, the company reported an asset turnover ratio of 0.30x, higher than the industry median figure of 0.22x. Below is captured the trend of EBITDA margin and revenue:

Section 2: Business Updates, Financial and Operational Highlights

2.1 Recent Updates:

2.2 Key Highlights for 1HFY22: Since 2018, the company has reported a top-line CAGR of ~8% on a constant currency basis. IRE remains on track to leverage the cloud infrastructure owing to elevated demand from its clients. The company has started the transition to the new single technology platform, which in turn, will aid the company to launch new products to market faster, and generate additional revenue growth.

2.3 Growth Strategies

Section 3: Key Risks and Outlook:

Section 4: Stock Recommendation Summary

4.1 Price Performance and Technical Summary:

4.2 Fundamental Valuation

Valuation Methodology: P/E Multiple Based Relative Valuation (Illustrative)

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is November 25, 2022. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

Disclaimer

Kalkine New Zealand Limited is a Financial Advice Provider (“FAP”) and is authorised by a Transitional FAP license issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity financial products. The recommendations and opinions [on this website] / [in this report] do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).  Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website.  Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.